Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid

Radiology

Volumn 256, Issue 2, 2010, Pages 475-484

  Kim, Kyung Ah ^a   Kim, Myeong Jin ^a   Park, Mi Suk ^a   Lim, Joon Seok ^a   Choi, Jin Young ^a   Hong, Hye Suk ^a   Kim, Ki Whang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; COMMON BILE DUCT; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; OBSERVER VARIATION; PANCREAS DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL NOISE RATIO; STUDENT T TEST; THREE DIMENSIONAL IMAGING; WILCOXON SIGNED RANKS TEST; BILIARY TRACT DISEASES; DIAGNOSTIC USE; IMAGE ENHANCEMENT; MIDDLE AGED; PANCREATIC DISEASES; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; PANCREATIC DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77955134121     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10091774     Document Type: Article

References (26)

1. Barish MA, Yucel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. N Engl J Med 1999;341(4):258-264.
2. Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM. Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 1998;207(1):21-32.
3. Vogl TJ, Schwarz WO, Heller M, et al. Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography. Eur Radiol 2006;16(10):2317-2325.
4. Kim JY, Lee JM, Han JK, et al. Contrast-enhanced MRI combined with MR cholangiopancreatography for the evaluation of patients with biliary strictures: differentiation of malignant from benign bile duct strictures. J Magn Reson Imaging 2007;26(2):304-312.
5. Kim SJ, Kim S, Kim CW, et al. Evaluation of the biliary tract: the value of performing magnetic resonance cholangiopancreatography in conjunction with a 3-D spoiled gradient-echo gadolinium enhanced dynamic sequence. Australas Radiol 2007;51(4):309-314. (Pubitemid 47052697)
6. Kim MJ, Mitchell DG, Ito K, Outwater EK. Biliary dilatation: differentiation of benign from malignant causes - value of adding conventional MR imaging to MR cholangiopancreatography. Radiology 2000;214(1):173-181. (Pubitemid 30019887)
7. Takahashi S, Kim T, Murakami T, et al. Infl uence of paramagnetic contrast on single-shot MRCP image quality. Abdom Imaging 2000;25(5):511-513. (Pubitemid 30659305)
8. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008;18(3):457-467.
9. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodiumenhanced MRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 2006;30(3):345-354.
10. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005;237(1):89-98.
11. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230(1):266-275.
12. Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol 2007;48(4):362-368.
13. Lim JS, Kim MJ, Kim JH, et al. Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine. AJR Am J Roentgenol 2005;185(2):424-431.
14. Carlos RC, Hussain HK, Song JH, Francis IR. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. AJR Am J Roentgenol 2002;179(1):87-92.
15. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Gadoliniumethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 1997;7(1):126-132.
16. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6(1):43-52.
17. Kim YK, Kwak HS, Kim CS, Han YM. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009;30(2):437-443.
18. Kanematsu M, Matsuo M, Shiratori Y, et al. Thick-section half-Fourier rapid acquisition with relaxation enhancement MR cholangiopancreatography: effects of i.v. administration of gadolinium chelate. AJR Am J Roentgenol 2002;178(3):755-761.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174.
20. Hamm B, Staks T, Mühler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195(3):785-792.
21. Ringe K, Gupta R, Reichel A, et al. MRCP after the injection of Gd-EOB-DTPA: Are 3 minutes safe for T2 weighted navigated 3D MRCP? [abstr]. In: Proceedings of the 17th meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009.
22. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40(11):715-724. (Pubitemid 41546838)
23. Papanikolaou N, Prassopoulos P, Eracleous E, Maris T, Gogas C, Gourtsoyiannis N. Contrast-enhanced magnetic resonance cholangiography versus heavily T2-weighted magnetic resonance cholangiography. Invest Radiol 2001;36(11):682-686. (Pubitemid 33021097)
24. Irie H, Honda H, Kuroiwa T, et al. Pitfalls in MR cholangiopancreatographic interpretation. RadioGraphics 2001;21(1):23-37.
25. Miyazaki T, Yamashita Y, Tsuchigame T, Yamamoto H, Urata J, Takahashi M. MR cholangiopancreatography using HASTE (half-Fourier acquisition single-shot turbo spin-echo) sequences. AJR Am J Roentgenol 1996;166(6):1297-1303.
26. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003;228(2):303-308.